130 related articles for article (PubMed ID: 1664295)
21. 2001 serological survey in the Czech Republic--poliomyelitis.
Matyásová I; Rainetová P; Cástková J
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
[TBL] [Abstract][Full Text] [Related]
22. [Third oral polio immunization--what is the good of it?].
Haas R; Petersen EE; Neumann-Haefelin D; Schnetter C
Dtsch Med Wochenschr; 1973 Mar; 98(10):476-9. PubMed ID: 4348024
[No Abstract] [Full Text] [Related]
23. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
[TBL] [Abstract][Full Text] [Related]
24. Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.
Osei-Kwasi M; Afari EA; Mimura K; Obeng-Ansah I; Ampofo WK; Nkrumah FK
Bull World Health Organ; 1995; 73(1):41-6. PubMed ID: 7704924
[TBL] [Abstract][Full Text] [Related]
25. [A seroepidemiological study on the level of immunological coverage in a nomadic population in Rome].
Porta D; Chierchini P; Bruno L; Fiore L; Cristofaro G; Amato C; Catone S; Gentili G; Sangalli M; Forastiere F
Epidemiol Prev; 1997; 21(1):48-53. PubMed ID: 9157025
[TBL] [Abstract][Full Text] [Related]
26. [Surveillance of levels of neutralizing antibodies against poliovirus among children aged 0-3 in rural areas of Anhui Province].
Shen Y; Zhao Y; Liu D
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):335-8. PubMed ID: 8697935
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional sero epidemiological prevalence of polio virus antibodies post-immunization with three doses of TOPV.
Tswana SA; Berejena C; Moyo SR; Mudyarabikwa O
Cent Afr J Med; 1994 Nov; 40(11):303-5. PubMed ID: 7859270
[TBL] [Abstract][Full Text] [Related]
28. [The use of immunomodulators to enhance postvaccinal immunity to experimental poliomyelitis].
Bondarenko VI; Zadorozhnaia VI; Buraia TA; Gritsenko LN
Mikrobiol Z; 1995; 57(6):41-5. PubMed ID: 8714398
[TBL] [Abstract][Full Text] [Related]
29. Antibody persistence after primary immunization with trivalent oral poliovirus vaccine.
Krugman RD; Hardy GE; Sellers C; Parkman PD; Witte JJ; Meyer BC; Meyer HM
Pediatrics; 1977 Jul; 60(1):80-2. PubMed ID: 195265
[TBL] [Abstract][Full Text] [Related]
30. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
[TBL] [Abstract][Full Text] [Related]
31. Polio immunization and serological status in children and adolescents in Jamaica (1985).
Ashley D; Fox K; Figueroa JP; Hull B
West Indian Med J; 1989 Mar; 38(1):23-9. PubMed ID: 2728430
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
33. Immunoprophylaxis in poliomyelitis.
John TJ
J Commun Dis; 1984 Mar; 16(1):38-42. PubMed ID: 12055784
[TBL] [Abstract][Full Text] [Related]
34. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
[TBL] [Abstract][Full Text] [Related]
35. Monovalent type 1 oral poliovirus vaccine in newborns.
el-Sayed N; el-Gamal Y; Abbassy AA; Seoud I; Salama M; Kandeel A; Hossny E; Shawky A; Hussein HA; Pallansch MA; van der Avoort HG; Burton AH; Sreevatsava M; Malankar P; Wahdan MH; Sutter RW
N Engl J Med; 2008 Oct; 359(16):1655-65. PubMed ID: 18923170
[TBL] [Abstract][Full Text] [Related]
36. Two research projects seek to improve immunization practices.
Bull Pan Am Health Organ; 1992; 26(1):96-7. PubMed ID: 1318142
[TBL] [Abstract][Full Text] [Related]
37. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin).
Dong DX; Hu XM; Liu WJ; Li JS; Jin YC; Tan SG; Chen TQ; Fu JZ; Niu BY; Yu HM
Bull World Health Organ; 1986; 64(6):853-60. PubMed ID: 3493854
[TBL] [Abstract][Full Text] [Related]
38. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
[TBL] [Abstract][Full Text] [Related]
40. Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two- and three-dose vaccination experiment.
Metselaar D; McDonald K; Gemert W; van Rens MM; Muller AS
Bull World Health Organ; 1977; 55(6):755-9. PubMed ID: 202418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
